Do Darden’s Earnings Signal a Broader Restaurant Recovery?

Photo of Chris Lange
By Chris Lange Published
Do Darden’s Earnings Signal a Broader Restaurant Recovery?

© Jonathan Weiss / Shutterstock.com

Darden Restaurants Inc. (NYSE: DRI | DRI Price Prediction) released its fiscal first-quarter financial results before the markets opened on Thursday. The company posted $0.28 in earnings per share (EPS) and $1.53 billion in revenue. That compares with consensus estimates of $0.05 in EPS and $1.56 billion in revenue, as well as the $1.38 per share and $2.13 billion reported in the same period of last year.

[in-text-ad]

During the latest quarter, total sales decreased 28.4% year over year, driven by negative blended same-restaurant sales of 29.0% and partially offset by the addition of 14 net new restaurants. In terms of its brands, Darden reported same-restaurant sales as follows:

  • Olive Garden, −28.2%
  • Longhorn Steakhouse, −18.1%
  • Fine Dining, −39.1%
  • Other Business, −39.0%

[nativounit]

On the books, Darden’s cash and cash equivalents totaled $654.6 million at the end of the quarter, down from $763.3 million at the end of the previous fiscal year. Considering the steadily improving cash flows in the quarter, and increased confidence in cash flow projections, the firm fully repaid its $270 million term loan in mid-August.

As it stands now, Darden has access to $1.4 billion of liquidity with $655 million of cash on hand and $750 million available through its credit facility.

Looking ahead to the fiscal second quarter, the company expects to see EPS in the range of $0.65 to $0.75 and total sales of roughly 82% of the prior year. Consensus estimates call for $0.35 in EPS and $1.78 billion in revenue for the quarter.

The board of directors declared that it has reinstated a quarterly dividend of $0.30 per share on common stock, which will be payable November 2, to shareholders of record at the close of October 9.

Darden stock traded up about 6% on Thursday, at $95.54 in a 52-week range of $26.15 to $124.01. The consensus price target is $92.67.

[recirclink id=769131][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

KMX Vol: 7,330,419
GLW Vol: 22,800,969
INTC Vol: 233,719,006
SMCI Vol: 68,465,534
ENPH Vol: 13,978,376

Top Losing Stocks

ACN Vol: 41,744,333
EPAM Vol: 5,636,587
CTSH Vol: 61,311,400
CTRA Vol: 73,319,495
KR Vol: 26,704,230